FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma

Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with rhabdomyosarcoma.

London scientists pioneer ‘game changing’ infrared imaging technique to treat child cancer

Heart Disease Risk Is Higher Among Childhood Cancer Survivors, Study Finds

Bone cancer drug could save children’s lives

Splicing Deregulation Detected and Targeted in Type of Childhood Leukemia

New study uncovers key culprit behind pediatric brain cancer metastasis

Safe to Skip Primary Tumor Boosts in Pediatric Germinomas

Scientists reveal how different cancer cells team up to help incurable childhood brain tumour spread

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Childhood Cancer Survivors Have Higher Rate of Aging-Related Mutations Than the General Population

Children’s Cancer Institute begins trial for childhood brain cancer therapy